Vitrolife AB
STO:VITR
Vitrolife AB
Revenue
Vitrolife AB
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Vitrolife AB
STO:VITR
|
Revenue
kr3.5B
|
CAGR 3-Years
39%
|
CAGR 5-Years
24%
|
CAGR 10-Years
22%
|
|
Biogaia AB
STO:BIOG B
|
Revenue
kr1.3B
|
CAGR 3-Years
20%
|
CAGR 5-Years
12%
|
CAGR 10-Years
N/A
|
|
Hansa Biopharma AB
STO:HNSA
|
Revenue
kr165.9m
|
CAGR 3-Years
127%
|
CAGR 5-Years
114%
|
CAGR 10-Years
51%
|
|
Bonesupport Holding AB
STO:BONEX
|
Revenue
kr655.8m
|
CAGR 3-Years
53%
|
CAGR 5-Years
46%
|
CAGR 10-Years
N/A
|
|
Swedish Orphan Biovitrum AB (publ)
STO:SOBI
|
Revenue
kr23.1B
|
CAGR 3-Years
17%
|
CAGR 5-Years
17%
|
CAGR 10-Years
26%
|
|
BioArctic AB
STO:BIOA B
|
Revenue
kr616m
|
CAGR 3-Years
115%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
N/A
|
See Also
What is Vitrolife AB's Revenue?
Revenue
3.5B
SEK
Based on the financial report for Mar 31, 2024, Vitrolife AB's Revenue amounts to 3.5B SEK.
What is Vitrolife AB's Revenue growth rate?
Revenue CAGR 10Y
22%
Over the last year, the Revenue growth was 5%. The average annual Revenue growth rates for Vitrolife AB have been 39% over the past three years , 24% over the past five years , and 22% over the past ten years .